Lung cancer and positron emission tomography with fluorodeoxyglucose.
Publication
, Journal Article
Marom, EM; Erasmus, JJ; Patz, EF
Published in: Lung Cancer
June 2000
Over the past years, positron emission tomography (PET) with fluoro-2-deoxy-D-glucose (FDG) has emerged as an important imaging modality. In the thorax, FDG-PET has been shown to differentiate benign from malignant pulmonary lesions and stage lung cancer. Preliminary studies have shown its usefulness in assessing tumor recurrence, and assisting in radiotherapy planning. FDG-PET is often more accurate than conventional imaging studies, and has been proven to be cost-effective in evaluating lung cancer patients. This review will discuss the current applications of FDG-PET as compared with conventional imaging in diagnosing, staging, and following patients with lung cancer.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lung Cancer
DOI
ISSN
0169-5002
Publication Date
June 2000
Volume
28
Issue
3
Start / End Page
187 / 202
Location
Ireland
Related Subject Headings
- Tomography, Emission-Computed
- Survival Rate
- Reproducibility of Results
- Radiopharmaceuticals
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Lung Neoplasms
- Humans
- Fluorodeoxyglucose F18
Citation
APA
Chicago
ICMJE
MLA
NLM
Marom, E. M., Erasmus, J. J., & Patz, E. F. (2000). Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer, 28(3), 187–202. https://doi.org/10.1016/s0169-5002(00)00096-9
Marom, E. M., J. J. Erasmus, and E. F. Patz. “Lung cancer and positron emission tomography with fluorodeoxyglucose.” Lung Cancer 28, no. 3 (June 2000): 187–202. https://doi.org/10.1016/s0169-5002(00)00096-9.
Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer. 2000 Jun;28(3):187–202.
Marom, E. M., et al. “Lung cancer and positron emission tomography with fluorodeoxyglucose.” Lung Cancer, vol. 28, no. 3, June 2000, pp. 187–202. Pubmed, doi:10.1016/s0169-5002(00)00096-9.
Marom EM, Erasmus JJ, Patz EF. Lung cancer and positron emission tomography with fluorodeoxyglucose. Lung Cancer. 2000 Jun;28(3):187–202.
Published In
Lung Cancer
DOI
ISSN
0169-5002
Publication Date
June 2000
Volume
28
Issue
3
Start / End Page
187 / 202
Location
Ireland
Related Subject Headings
- Tomography, Emission-Computed
- Survival Rate
- Reproducibility of Results
- Radiopharmaceuticals
- Oncology & Carcinogenesis
- Neoplasm Staging
- Neoplasm Recurrence, Local
- Lung Neoplasms
- Humans
- Fluorodeoxyglucose F18